October 12, 2021

Microlyte® SURGICAL Associated with Positive Outcomes in Prospective Clinical Case Series in Patients at Risk for Surgical Site Infection

MADISON, Wis.–(BUSINESS WIRE)– #InfectionPrevention–Imbed Biosciences, Inc. (Imbed) announced today the results of a prospective clinical evaluation of its next-generation wound matrix, Microlyte® SURGICAL, in diabetic patients undergoing foot and ankle surgery who would ordinarily be at risk of a surgical site infection. Results will be published in the October issue of WOUNDS, a widely read, peer-reviewed journal in wound care and research. In the study conducted by Ryan Chatelain, DPM at East Tennessee State Un

Leave Comment

Your Name *
Your Email *
Your Website
Comment *